None listed
Conditions
Brief summary
Aneurysmal subarachnoid haemorrhage (aSAH) is a rare but devastating form of stroke caused by a ruptured brain aneurysm that kills at least 30% of sufferers within 1 month. Up to 50% of people with aSAH will experience delays greater than 24 hours between onset of aSAH and receiving treatment. This study aims to quantify the time delays in treatment of aSAH for patients across Tasmania and South-East Victoria.
Interventions
The study will audit the medical records of first-ever aneurysmal subarachnoid haemorrhage occurring within the referral networks of two tertiary hospitals between 2010 and 2016. The retrospective study design is due to the low incidence of aSAH (~9/100,000 people per year).
Sponsors
University of Tasmania
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
We will include cases of first-ever aneurysmal subarachnoid haemorrhage occurring within the referral networks of two tertiary hospitals between 2010 and 2016.
Exclusion criteria
1. People who have experienced a subarachnoid haemorrhage that has not occurred secondary to the rupture of an aneurysm, including individuals with arteriovenous malformations or haemorrhages secondary to infectious and traumatic events, and or extensions of ICH, where the primary cause has not been aneurysmal. 2. In Tasmania only, Individuals will also be excluded if their usual residence was not Tasmania. 3. Individuals re-presenting to hospital following for adverse events following the securement of their aneurysm, unless a second aneurysm had ruptured during the study period. 4. Aneurysm rupture occurred outside of the study period 1/1/2010 to 31/12/2016
Outcome results
None listed